Intensive Review of Nephrology 2020 (Videos)

Explore Key Topics in Nephrology

Through lectures, case discussions and board preparation sessions, Intensive Review of Nephrology provides a highly focused look at all major fields of nephrology. Harvard Medical School clinical faculty help you stay current and prepare for exams as they discuss:

• The latest options for diagnosis: what to choose, when, and why
• Current evidence-based treatment and care management strategies to optimize patient outcomes
• Improved approaches to common and complex clinical challenges
• Navigating clinical controversies
• Avoiding medical mistakes
• And more…

Expand Your Skills

Available online or via USB, Intensive Review of Nephrology provides a maximum of 44.75 AMA PRA Category 1 Credits ™ and 44.75 ABIM MOC points and access to unbiased, evidence-based content and case-based reviews so you can prep for exams while learning to incorporate the latest guidelines into your daily practice.

Date of Original Release: October 15, 2020
Termination Date: January 31, 2023

Topics/speakers:

Glomerulonephritis

• Renal Physiology for the Boards – Melanie P. Hoenig, MD

• Basic Concepts of Immunology in Autoimmune Kidney Disease – Ramon Bonegio, MD

• Renal Pathology in 2020: Part 1 – Helmut G. Rennke, MD

• Renal Pathology in 2020: Part 2 – Astrid Weins, MD, PhD

• Current Approaches to Urine Sediment Analysis – Martina M. McGrath, MD

• IgA Nephropathy – Gerald B. Appel, MD

• Membranous Nephropathy – Laurence H. Beck, Jr., MD, PhD

• ANCA Vasculitis – John L. Niles, MD

• Update on Lupus Nephritis – Gerald B. Appel, MD

• Metabolic Management of Kidney Stones – Gary Curhan, MD, ScD

• Anemia Management: Update and Best Practices – Ajay K. Singh, MBBS, FRCP (UK), MBA

• Glomerulonephritis: Questions & Answers Session – Gerald B. Appel, MD

• Must-Know Clinical Images in Nephrology – Ajay K. Singh, MBBS, FRCP (UK), MBA

• Must-Know Board Zebra – Emily Robinson, MD, MPH

• Nephrology Board Review Practice 1 – Finnian McCausland, MB BCh, MMSc, FRCPI

• Nephrology Board Review Practice 2 – Mallika Mendu, MD

Electrolytes and Acid Base

• Workshop: Hyponatremia and Hypernatremia – David B. Mount, MD

• Hypokalemia and Hyperkalemia – David B. Mount, MD

• Acid-Base Part I – Acidosis – Alan S.L. Yu, MB, BChir

• Acid-Base Part II – Alkalosis – Alan S.L. Yu, MB, BChir

• COVID-19 and Kidney Disease – Daniel Batlle, MD

• Genetics and Kidney Disease – Friedhelm Hildebrandt, MD

• Update on Polycystic Kidney Disease – Cristian Riella, MD

• Pediatric Nephrology – Michael J.G. Somers, MD

• Pregnancy and Renal Disease – Ravi I. Thadhani, MD, MPH

• Electrolyte and Acid Base Disorders – Questions & Answers Session – Part 1 – Alan S.L. Yu, MB, BChir

• Electrolyte and Acid Base Disorders – Questions & Answers Session – Part 2 – Alan S.L. Yu, MB, BChir

• Chronic Kidney Disease in the Community: Meeting Them Where They Are – Li-Li Hsiao, MD, PhD, FACP

Transplantation

• Why Do We Reject a Transplant? – Jamil R. Azzi, MD

• Transplant Immunosuppression for the Boards – Steven Gabardi, PharmD, BCPS, FAST, FCCP

• Immunological Assessment Pre and Post Transplant – Melissa Y. Yeung, MD and Indira Guleria, PhD

• Early Post-Transplant Management – Anil K. Chandraker, MD

• Poisonings and Intoxications: What a Nephrologist Needs to Know – Timothy B. Erickson, MD

• Late Loss of the Kidney Transplant – Andrew M. Siedlecki, MD

• Infections in Transplant Recipients – Sarah P. Hammond, MD

• COVID-19 and Transplant Patients – Enver Akalin, MD, FAST, FASN

• Renal Transplant Recipient Medical Evaluation – Jamil R. Azzi, MD

• Pre-Transplant Surgical Evaluation of Recipients – Sayeed Malek, MD, FACS

• Donor Evaluation – Kassem Safa, MD

• Late Post-Transplant Medical Complications – Leonardo V. Riella, MD, PhD

• Thrombotic Microangiopathies – Jean M. Francis, MD

• Geriatric Nephrology – Ernest I. Mandel, MD

• Transplant Cases: Board Review Practice – Melissa Y. Yeung, MD, and Edgar L. Milford, MD

• Transplant Board Review – Leonardo V. Riella, MD, PhD

CKD and General Nephrology

• Update on Renovascular Disease – Joseph M. Garasic, MD

• Management of Hypertension after SPRINT – Richard J. Glassock, MD

• Secondary Hypertension: Primary Aldosteronism and Pheochromocytoma – Anand Vaidya, MD, MMSc

• Cardiorenal Syndrome – Finnian R. McCausland, MB BCh, MMSc, FRCPI

• Liver and the Kidney – Andrew S. Allegretti, MD, MSc

Acute Kidney Injury

• Pathophysiology of Acute Kidney Injury – Joseph V. Bonventre, MD, PhD

• Acute Kidney Injury Syndromes – Alice Sheridan, MD

• ICU Nephrology and Continuous Renal Replacement Therapies – David J.R. Steele, MB BCh

• COVID-19 in the ICU – Jeremy B. Richards, MD

• Cancer and Acute Kidney Injury – Albert Q. Lam, MD

• Paraprotein Induced Kidney Injury – Albert Q. Lam, MD

• FSGS: A Lesion, Not a Disease – Richard J. Glassock, MD

• Interstitial Nephritis: Overview for the Boards – Julie M. Paik, MD, ScD, MPH

• APOL1 and Kidney Disease – Martin R. Pollak, MD

Dialysis

• Dialysis Dosing – J. Kevin Tucker, MD

• Mineral and Bone Disease – David Bushinsky, MD

• Dialysis: A Case-Based Clinical Review and Update – J. Kevin Tucker, MD

• Pearls in Mineral and Bone Disease – David Bushinsky, MD

• Chronic Kidney Disease Epidemiology: A 2019 Update – Gearoid M. McMahon, MB BCh

• Peritoneal Dialysis – Joanne M. Bargman, MD, FRCPC

• Peritoneal Dialysis Complications – Joanne M. Bargman, MD, FRCPC

• COVID-19 and Patients on Dialysis – Giuliano Brunori, MD

• Renal Ultrasound for the Clinical Nephrologist – Adina S. Voiculescu, MD

• Dialysis Vascular Access: Assessment and Complications – Dirk M. Hentschel, MD